Atossa Therapeutics, Inc. (ATOS) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
7/25
Growth 1
Margin 0
Expansion 3
Platform 0
Financial 3
latest quarter score
Earnings Reports
- 7